Concepedia

Maribavir Use in Practice for Cytomegalovirus Infection in French Transplantation Centers

Sophie Alain, Matthieu Revest, David Veyer, Marie Essig, J. P. Rerolles, William D. Rawlinson, Catherine Mengelle, A. Huynh, Nassim Kamar, Isabelle Garrigue,

Transplantation Proceedings · 2013 · 48 citations · 10 references

DOI

Concepts

References

10

Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial

Francisco M. Marty, Per Ljungman, Genovefa A. Papanicolaou et al. · The Lancet Infectious Diseases · 2011 · 350 citations

, , +17

Emergence of drug‐resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes

Albert Eid, Supha K. Arthurs, Paul J. Deziel et al. · Clinical Transplantation · 2007 · 174 citations

, , +17

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study

Sébastien Hantz, F. Garnier-Geoffroy, Marie‐Christine Mazeron et al. · Journal of Antimicrobial Chemotherapy · 2010 · 163 citations · Full text

, , +17

Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients

Robin K. Avery, Francisco M. Marty, Lynne Strasfeld et al. · Transplant Infectious Disease · 2010 · 133 citations

, , +17

Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir

Guy Boivin, Nathalie Goyette, Halvor Rollag et al. · Antiviral Therapy · 2009 · 109 citations · Full text

, , +17